Ionis Pharmaceuticals (IONS) Other financing activities (2009 - 2023)

Ionis Pharmaceuticals' Other financing activities history runs 9 years deep, the most recent figure standing at -$14.2 million for Q4 2023.

• In Q4 2023, Other financing activities fell 229.42% year-over-year to -$14.2 million; the TTM figure through Dec 2024 stood at -$13.7 million (down 562.69% YoY), while the FY2025 annual figure was $18.9 million, changed N/A from the prior year.
• Other financing activities was -$14.2 million for Q4 2023 at Ionis Pharmaceuticals, down from $517000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $15.3 million in Q1 2021 to a low of -$14.2 million in Q4 2023.
• Historically, Other financing activities has averaged $3.3 million across 5 years, with a median of $517000.0 in 2023.
• The sharpest annual moves came in 2022 and 2023: Other financing activities surged 2389.32% in 2022, then sank 229.42% in 2023.
• A 5-year view of Other financing activities shows it stood at $401000.0 in 2019, then surged by 146.88% to $990000.0 in 2020, then tumbled by 55.56% to $440000.0 in 2021, then soared by 2389.32% to $11.0 million in 2022, then tumbled by 229.42% to -$14.2 million in 2023.
• The last three Other financing activities figures came in at -$14.2 million (Q4 2023), $517000.0 (Q3 2023), and $11.0 million (Q4 2022), per Business Quant data.